|
1
|
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.
|
Clin Cancer Res
|
2003
|
2.73
|
|
2
|
Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.
|
Cardiovasc Intervent Radiol
|
2012
|
1.09
|
|
3
|
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.
|
Cancer Immun
|
2007
|
0.96
|
|
4
|
Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma.
|
J Vasc Interv Radiol
|
2009
|
0.83
|
|
5
|
Liver transplantation after radioembolization in a patient with unresectable HCC.
|
Nat Rev Gastroenterol Hepatol
|
2009
|
0.76
|